Regina Toal
Adult Health · Havre de Grace, MDNPI 1003100652
Payments from drug & device makers
Across 80 payments — averaging $24.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$699
- Novo Nordisk$265
- Lilly USA, LLC$172
- AbbVie$98
- Abbott$78
- Intuitive Surgical$77
- plus $599 from 22 others
What the payments were for
- Food & beverage$1,987100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 18 | $699 |
| Novo Nordisk | 11 | $265 |
| Lilly USA, LLC | 8 | $172 |
| AbbVie | 5 | $98 |
| Abbott | 4 | $78 |
| Intuitive Surgical | 1 | $77 |
| GSK | 4 | $61 |
| Pfizer | 3 | $59 |
| Amgen | 3 | $50 |
| Dynavax Technologies Corporation | 2 | $50 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Astellas Pharma US Inc | 2 | $37 |
| Idorsia Pharmaceuticals US Inc | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| Exact Sciences | 1 | $25 |
| Sunovion Pharmaceuticals Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Bayer | 1 | $22 |
| Dexcom, Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Acadia Pharmaceuticals Inc | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Merck | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| IBSA Pharma Inc. | 1 | $13 |
| Medtronic | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,987 in reported general payments places this provider in the 80th percentile of 542 adult health providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 39 | $31,253 |
| TrulicityDulaglutide | 18 | $28,153 |
| XareltoRivaroxaban | 12 | $14,286 |
| JardianceEmpagliflozin | 12 | $13,377 |
| RybelsusSemaglutide | 13 | $12,463 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 13 | $6,233 |
| SynthroidLevothyroxine Sodium | 67 | $5,213 |
| Rosuvastatin Calcium | 215 | $4,652 |
| Metoprolol Succinate | 226 | $3,713 |
| Atorvastatin Calcium | 248 | $3,173 |
| Ezetimibe-SimvastatinEzetimibe/Simvastatin | 15 | $2,856 |
| Bisoprolol-HydrochlorothiazideBisoprolol/Hydrochlorothiazide | 34 | $2,531 |
| Levothyroxine Sodium | 231 | $2,467 |
| Ezetimibe | 73 | $2,405 |
| Losartan Potassium | 153 | $1,971 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $59 | $31,25339 claims |
| Lilly USA, LLCTrulicity | $172 | $28,15318 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $14 | $19,61025 claims |
| Novo NordiskRybelsus | $265 | $12,46313 claims |
| AbbVieSynthroid | $98 | $5,21367 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 542 adult health providers in Maryland.
Other adult health in Havre de Grace
- Lucia NovakCamp Springs$473K
- Caroline RuhlAnnapolis$315K
- Joyce MiskovicHighland$264K
- Christopher RobersonBaltimore$180K
- Amit DhirBaltimore$97K
- Angie PriceBaltimore$96K
- Morgan JoliatSykesville$92K
- Brendon BowerBaltimore$64K
- Caitlin NassBaltimore$46K
- Jane KapustinClarksville$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.